Adagene (ADAG) links director option vesting to next report
Rhea-AI Filing Summary
Adagene Inc. director Zhu Li received a grant of 20,000 nonqualified stock options on August 13, 2026 under the Adagene Inc. 2021 Performance Incentive Plan. The options have an exercise price of $3.00 per ordinary share, expire on August 13, 2036, and increase Li’s directly held option position to 90,000 options.
According to the grant terms, the options will vest on April 30, 2027 or on the date of the next Form 20-F filing, whichever occurs earlier, tying vesting to a specific future company reporting milestone.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Zhu Li
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Nonqualified Stock Option (Right to Buy) F1 | 20,000 | $0.00 | $0.00 |
Holdings After Transaction:
Nonqualified Stock Option (Right to Buy) — 90,000 shares (Direct)
Footnotes (1)
- F1. 20,000 shares of stock option granted on August 13, 2026 under the Adagene Inc. 2021 Performance Incentive Plan, and the option shall vest on April 30, 2027 or the date of the next 20-F filing, whichever is earlier.
Key Figures
Options granted: 20,000 options
Exercise price: $3.00 per share
Expiration date: August 13, 2036
+3 more
6 metrics
Options granted
20,000 options
Nonqualified stock options granted on August 13, 2026 under the 2021 Performance Incentive Plan
Exercise price
$3.00 per share
Conversion or exercise price for the 20,000 newly granted options
Expiration date
August 13, 2036
Expiration date of the 20,000 nonqualified stock options
Underlying shares
20,000 ordinary shares
Number of ordinary shares underlying the newly granted options
Total options after grant
90,000 options
Total derivative securities beneficially owned following the reported transaction
Vesting date trigger
April 30, 2027
Vests on April 30, 2027 or the date of the next Form 20-F, whichever is earlier
Key Terms
Nonqualified Stock Option, Performance Incentive Plan, Form 20-F
3 terms
Nonqualified Stock Option financial
"Nonqualified Stock Option (Right to Buy)"
A nonqualified stock option (NQSO) is a company grant that gives an individual the right to buy shares at a set price but does not meet special tax rules for incentive stock options; when exercised the difference between the market price and the exercise price is treated as ordinary income for the recipient and as a tax-deductible expense for the company. It matters to investors because NQSOs affect an employee’s after-tax proceeds, the company’s reported expenses, and potential share dilution—think of it like a cash bonus that converts into stock but is taxed as regular pay when you take it.
Performance Incentive Plan financial
"under the Adagene Inc. 2021 Performance Incentive Plan"
Form 20-F regulatory
"or the date of the next 20-F filing, whichever is earlier"
Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.
FAQ
What transaction did Zhu Li report in the Form 4 for ADAG?
Zhu Li reported a grant of 20,000 nonqualified stock options for Adagene Inc. on August 13, 2026. These derivative awards give the right to buy ordinary shares at a fixed exercise price in the future, subject to vesting conditions.
What is the exercise price and expiration date of Zhu Li’s new ADAG options?
The granted options have an exercise price of $3.00 per share and expire on August 13, 2036. This means Zhu Li can purchase Adagene ordinary shares at $3.00 any time after vesting and before the stated expiration date, if the options are in the money.
When do Zhu Li’s newly granted ADAG stock options vest?
The 20,000 stock options vest on April 30, 2027 or on the date of Adagene’s next Form 20-F filing, whichever is earlier. Vesting must occur before the options become exercisable, linking the award to a future financial reporting milestone.
How many ADAG options does Zhu Li hold after this reported grant?
Following this grant, Zhu Li holds 90,000 stock options in total on a direct basis. The Form 4 lists this figure as the total number of derivative securities beneficially owned after the reported transaction, reflecting accumulated option awards.
Is Zhu Li’s Form 4 transaction for ADAG a market purchase or a compensation award?
The filing shows a compensation-related grant, coded as a grant, award, or other acquisition (transaction code A), not a market purchase. The nonqualified stock options were granted under the Adagene Inc. 2021 Performance Incentive Plan at no purchase price on the grant date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
